NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer. - Pratas Guerra L; Sá E Silva R; Simões J; Quinto Pereira M; Gonçalves L; Couto M; Gonçalves MB; Neves S; Martins Braga M; Queirós Coelho J; Sousa MJ; Romão R; et al. (Cureus, 2026)